|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7500 NOK | +1.35% |
|
+7.14% | -45.65% |
| Jun. 30 | Exact Therapeutics to Delist from Euronext Growth Oslo in October | MT |
| Jun. 26 | EXACT Therapeutics AS Gets Positive Safety Review For 60 ?l/Kg Dose In Phase 2 ENACT Trial | RE |
| Market Cap | 47.45M 5M 4.32M 4.04M 3.7M 6.96M 475M 7.07M 47.35M 18.58M 238M 18.76M 18.35M 788M | P/E 2024 |
-2.49x | P/E 2025 | -1x |
|---|---|---|---|---|---|
| Enterprise Value | 23.54M 2.48M 2.14M 2M 1.84M 3.45M 236M 3.51M 23.49M 9.22M 118M 9.31M 9.1M 391M | EV / Sales 2024 |
-
| EV / Sales 2025 | 1,074,437,000x |
| Free-Float |
30.97% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +1.35% | ||
| 1 week | +7.14% | ||
| Current month | +7.14% | ||
| 3 months | -45.65% | ||
| 6 months | -60.11% | ||
| Current year | -45.65% |
| 1 week | 0.68 |  | 0.8 |
| 1 month | 0.64 | | 0.8 |
| Current year | 0.58 | | 2.7 |
| 1 year | 0.58 | | 2.98 |
| 3 years | 0.58 | | 20 |
| 5 years | 0.58 | | 24 |
| 10 years | 0.58 | | 53.59 |
| Manager | Title | Age | Since |
|---|---|---|---|
Svein Kvåle
COO | Chief Operating Officer | - | 2011-12-31 |
Per Walday
CEO | Chief Executive Officer | 66 | 2022-06-05 |
John Edminson
DFI | Director of Finance/CFO | - | 2022-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 55 | 2018-06-21 | |
Anders Wold
CHM | Chairman | - | 2022-06-07 |
| Director/Board Member | 59 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 1/4/23 | Buy | Chairman | 2,500 | 0.0083% | ||
| 1/4/23 | Buy | Founder | 2,500 | 0.0083% | ||
| 1/4/23 | Buy | Chief Financial Officer | 2,500 | 0.0083% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.35% | +7.14% | -72.01% | -93.75% | 5M | |
| +0.37% | +2.28% | +5.88% | +15.04% | 49.47B | |
| +3.71% | +9.40% | +486.14% | +592.61% | 43.97B | |
| +5.60% | +10.21% | +20.85% | +73.63% | 39.6B | |
| +2.70% | +1.57% | +32.71% | +9.15% | 39.29B | |
| +2.21% | +6.75% | +20.20% | +47.53% | 32.43B | |
| +2.23% | +4.71% | - | - | 16.84B | |
| +0.97% | +2.35% | +35.99% | +122.50% | 16.49B | |
| -0.40% | +2.63% | +4.92% | +17.91% | 14.01B | |
| +0.75% | +15.04% | +79.84% | +23.95% | 12.77B | |
| Average | +1.95% | +6.40% | +68.28% | +89.84% | 26.49B | |
| Weighted average by Cap. | +2.41% | +6.10% | +105.29% | +137.86% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 0.06 0.01 0.01 0.01 0 0.01 0.59 0.01 0.06 0.02 0.3 0.02 0.02 0.98 |
| Net income | -52.33M -5.51M -4.77M -4.45M -4.08M -7.68M -524M -7.8M -52.22M -20.5M -263M -20.69M -20.24M -869M | -86.97M -9.16M -7.92M -7.4M -6.79M -12.76M -871M -12.97M -86.78M -34.06M -437M -34.39M -33.63M -1.44B |
| Net Debt | -98.89M -10.41M -9.01M -8.41M -7.72M -14.51M -991M -14.74M -98.68M -38.73M -497M -39.1M -38.24M -1.64B | -23.91M -2.52M -2.18M -2.03M -1.87M -3.51M -240M -3.56M -23.86M -9.37M -120M -9.45M -9.25M -397M |
Employees
11
Calendar
Sep. 02
Earnings release - Q2 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-07 | NOK 0.7500 | +1.35% | 5,200 |
| 26-08-06 | NOK 0.7400 | +8.82% | 12,381 |
| 26-08-05 | NOK 0.6800 | -15.00% | 54,312 |
| 26-08-04 | NOK 0.8000 | 0.00% | 0 |
| 26-08-03 | NOK 0.8000 | +14.29% | 30,250 |
- Stock Market
- Stocks
- EXTX Stock
Select your edition
All financial news and data tailored to specific country editions
